drugset / Trial / NCT00002475
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Vaccines made from a patient's tumor tissue may make the body build an immune response to kill tumor cells. Chemotherapy combined with vaccine therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining cyclophosphamide with tumor cell vaccine in treating patients who have metastatic cancer or cancer at high risk of recurrence.
Timeline
- Start
- 1991-04
- Primary completion
- 2007-12
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Subject | allogeneic tumor cell vaccine | Vaccine | — | Intramuscular |
| Subject | autologous tumor cell vaccine | Vaccine | — | Intramuscular |
| Background | Interferon gamma-1b | Protein / enzyme biologic | — | — |
| Background | interferon alfa-2b | Protein / enzyme biologic | — | — |
| Background | sargramostim | Protein / enzyme biologic | — | Subcutaneous |